Alcidion Group Limited ( (AU:ALC) ) has provided an update.
Alcidion Group Limited has announced the appointment of Andrew Way as a director, effective from April 15, 2025, as per the ASX listing rule 3.19A.1. This appointment is part of Alcidion’s ongoing efforts to strengthen its leadership team, potentially impacting its strategic direction and market positioning in the healthcare technology sector.
More about Alcidion Group Limited
Alcidion Group Limited is a company focused on transforming healthcare through innovative technology solutions. It offers a suite of software products and technical services, with its flagship product Miya Precision, aimed at enhancing patient care efficiency and quality. The company operates globally, serving over 400 hospitals and 87 healthcare organizations, with a significant presence in the UK, Australia, and New Zealand.
YTD Price Performance: 20.0%
Average Trading Volume: 1,944,237
Technical Sentiment Signal: Buy
Current Market Cap: A$96.69M
See more insights into ALC stock on TipRanks’ Stock Analysis page.